No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs375834258 |
chr3:116076450-116076451 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs563958130 |
chr3:116076459-116076460 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs531165895 |
chr3:116076477-116076478 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs549308518 |
chr3:116076489-116076490 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs78070974 |
chr3:116076492-116076493 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs12488477 |
chr3:116076496-116076497 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs143737277 |
chr3:116076512-116076513 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs546592887 |
chr3:116076515-116076516 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs76741326 |
chr3:116076524-116076525 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs367656796 |
chr3:116076574-116076575 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs538631647 |
chr3:116076593-116076594 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs114796184 |
chr3:116076602-116076603 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs569847987 |
chr3:116076608-116076609 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs537289367 |
chr3:116076627-116076628 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs374368960 |
chr3:116076641-116076642 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs142602368 |
chr3:116076642-116076643 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs116584066 |
chr3:116076675-116076676 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs567036939 |
chr3:116076701-116076702 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs80294375 |
chr3:116076764-116076765 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs79411508 |
chr3:116076765-116076766 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs201324262 |
chr3:116076772-116076773 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs146405574 |
chr3:116076780-116076781 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs77833751 |
chr3:116076794-116076795 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs537741289 |
chr3:116076839-116076840 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs73149192 |
chr3:116076845-116076846 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs141487532 |
chr3:116076852-116076853 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs369148478 |
chr3:116076861-116076862 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs150849485 |
chr3:116076881-116076882 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs138617092 |
chr3:116076954-116076955 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs199866909 |
chr3:116076960-116076961 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs190300107 |
chr3:116076961-116076962 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs577948546 |
chr3:116077009-116077010 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs376083281 |
chr3:116077013-116077014 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs540360207 |
chr3:116077021-116077022 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs113158585 |
chr3:116077061-116077062 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs533962789 |
chr3:116077119-116077120 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs565016177 |
chr3:116077176-116077177 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs34642483 |
chr3:116077197-116077198 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
39 |
rs149298666 |
chr3:116077231-116077232 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs569940162 |
chr3:116077257-116077258 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs144526554 |
chr3:116077280-116077281 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs111787923 |
chr3:116077308-116077309 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs549180423 |
chr3:116077375-116077376 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs139428474 |
chr3:116077388-116077389 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs116474113 |
chr3:116077418-116077419 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs553134538 |
chr3:116077424-116077425 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs571364998 |
chr3:116077465-116077466 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs543195823 |
chr3:116077467-116077468 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs142639436 |
chr3:116077468-116077469 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs375153234 |
chr3:116077472-116077473 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|